When was MolecularMatch founded?

MolecularMatch was founded in 2013 and raised its 1st funding round 1 year after it was founded.

Where is MolecularMatch located?

MolecularMatch is headquartered in Houston, United States.

Who is the current CEO of MolecularMatch?

Kevin Coker and Eric Pulaski s of MolecularMatch.

How many employees does MolecularMatch have?

As of May 31, 2026, the latest employee count at MolecularMatch is 3.

Is MolecularMatch a funded company?

MolecularMatch is a funded company, having raised a total of $3.69M across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on 2014.

When was the latest funding round of MolecularMatch?

MolecularMatch's latest funding was a $***** Series A round on Aug 05, 2014, with participation from 1 investor. Its primary sector is Genomics. In United States, the Genomics sector has seen $1.3B in funding in 2026 to date.

Where does MolecularMatch rank among its competitors?

MolecularMatch ranks 110th amongst 670 active competitors, of which 126 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was myTomorrows, which secured $29M in Nov, 2025.

Who are the top competitors of MolecularMatch?

MolecularMatch's top competitors include Evidation, Benchling and Helix. Among them, myTomorrows secured the most recent funding round in November, 2025.

MolecularMatch - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of clinical intelligence platform for precision oncology and immunotherapy. The platform facilitates clinical decision support through a rapid learning system. It automates molecular knowledge aggregation, allowing organizations to augment their offerings. The technology scales to provide evidence-based recommendations, supporting high patient volume. It delivers personalized results through a biomedical ontology with natural language processing and machine learning. The automated technology reduces manually intensive processes associated with molecular recommendations. The system integrates to complement existing workflows.

Website: molecularmatch.com
Social

Key Metrics

Founded Year

2013

Location

Houston, United States

Stage

Series A

Total Funding

$3.69M in 2 rounds

Latest Funding Round

Series A, Aug 05, 2014, $*****

Investors

Houston Angel Network & 4 more

Ranked

110^th among 670 active competitors

Employee Count

3 as on May 31, 2026

Similar Companies

Evidation & 911 more

View MolecularMatch's full profile

MolecularMatch is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
MOLECULARMATCH, INC. CIN: 32054304442 , United States, Active	Jun 10, 2014	-	-	-
MolecularMatch, Inc. CIN: 464179020 , United States, Active	Jun 13, 2013	-	6 (As on Dec 31, 2014)	-

MolecularMatch has raised a total funding of $3.69M over 2 rounds. Its first funding round was on 2014. Its latest funding round was a Series A round on Aug 05, 2014 for $*****. 1 investor participated in its latest round. MolecularMatch has 5 institutional investors.

Here is the list of recent funding rounds of MolecularMatch:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 05, 2014	7633248	Series A	4404872	8798140	4508174	9413464
2014	7289	Series A	8757	5473	Houston Angel Network	8142

Access funding benchmarks and valuations. Sign up today!

View details of MolecularMatch's funding rounds and investors

The founders of MolecularMatch are Nick Tackes, James Welsh and Ryan Smith.

Here are the details of MolecularMatch's key team members:

Nick Tackes: Co-Founder & CTO of MolecularMatch.
James Welsh: Co-Founder & CMO of MolecularMatch.
Ryan Smith: Co-Founder of MolecularMatch.
Kevin Coker: Co-Founder & CEO of MolecularMatch.
Eric Pulaski: Former Founder of MolecularMatch.
Contact Info: 1 email address

View details of MolecularMatch's Founder profiles and Board Members

MolecularMatch's employee count trend

MolecularMatch has 3 employees as of May 26. Here is MolecularMatch's employee count trend over the years:

Uncover MolecularMatch's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of MolecularMatch include Evidation, Benchling and Helix. Here is the list of Top 10 competitors of MolecularMatch, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Evidation 2012, Menlo Park (United States), Series E	Real-world health data insights for better healthcare decisions and research	$259M	B Capital, Sanofi Ventures & 16 others	74/100
2nd	Benchling 2012, San Francisco (United States), Series F	Provider of a cloud-based bioinformatics platform for biotech research	$412M	Altimeter Capital, Menlo Ventures & 28 others	73/100
3rd	Helix 2015, San Francisco (United States), Series E	Provider of a genomic database for clinical research	$435M	DFJ Growth, Kleiner Perkins & 12 others	71/100
4th	myTomorrows 2012, Amsterdam (Netherlands), Series C	Platform provides access to drugs in development to patients and physicians	$51.3M	EQT, Balderton Capital & 5 others	69/100
5th	Antidote 2010, North Miami Beach (United States), Series C	Provider of patient recruitment and matching services for clinical trials	$52M	Merck Global Health Innovation Fund, Amadeus Capital ... & 5 others	65/100
6th	Congenica 2013, Cambridge (United Kingdom), Acquired	Developer of software for clinical genomic interpretation and variant analysis	$81.9M	IDO Investments, Xeraya Capital & 39 others	62/100
7th	SubjectWell 2012, Austin (United States), Acquired	Provider of clinical trials marketplace offering solutions for patient recruitment	$46.8M	Windham Venture Partners, Asset Management Ventures ... & 10 others	60/100
8th	Dyania Health 2019, Sacramento (United States), Series A	Developer of an AI platform for healthcare data extraction and analysis	$15.3M	HealthX Ventures, Innospark & 13 others	60/100
9th	Trialbee 2010, Malmo (Sweden), Acquired	Cloud based clinical trial recruitment solutions for pharmaceutical companies, analytics, services	$27.1M	MTIP, Industrifonden & 5 others	59/100
10th	Latch 2021, San Francisco (United States), Series A	Provider of a web-based platform for genomic bioinformatics	$33M	Lux Capital, Coatue & 7 others	59/100
110th	MolecularMatch 2013, Houston (United States), Series A	Provider of clinical intelligence platform for precision oncology and immunotherapy	$3.69M	GOOSE Capital, Flight Partners Capital & 3 others	36/100